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ABSTRACT OF THE THESIS 
 
 
 
 
Aryl Hydrocarbon Receptor-Mediated Induction of CYP1A1 and CYP1B1 Enzymes in 
Brain: A Preliminary Exploration of the Role of Oxylipins in Lung Cancer Metastasis to 
Brain 
 
 
 
 
 
 
 
by 
 
 
 
 
Zhen Tong 
 
Master of Science in Environmental Health Sciences 
 
University of California, Los Angeles, 2020 
 
Professor Oliver Hankinson, Chair 
 
 
 
 
Lung cancer is one of the most frequent diagnosis cancers in the U.S. Importantly, 
primary lung cancer frequently metastasizes to the brain, but the survival and treatment 
of lung cancer brain metastasis are both poor. Aryl Hydrocarbon Receptor (AHR) 
mediated induction of Cytochrome P450 enzymes has been linked to cancer 
progression via binding to AHR agonists like 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin 
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(TCDD). The exposure of TCDD significantly increases CYP 1A1 and CYP 1B1 in the 
lung and liver.  
The western diet typically contains a high ratio of omega-6 (-6) to omega-3 (-3) 
polyunsaturated fatty acids (PUFA). Recently, our group has demonstrated that the 
action of -6 and -3 PUFA metabolism on tumor progression is an AHR dependent 
process. TCDD promotes tumor growth and metastasis under -6 enriched diets but 
inhibits tumor growth and metastasis under -3 enriched diets. This finding indicates 
that TCDD impact on lung cancer progression can be modified by dietary PUFA. Based 
on this new research ground, it is also interesting to evaluate TCDD's action on primary 
lung cancer metastasis to brain depending on different ratio of -6 to -3 PUFA in diet.  
We hypothesized that the lung tumor increases the metastasis to brain through an AHR 
agonist like TCDD, which induce the expression of some cytochrome P450 in the brain 
of the mice that were fed with rich-⍵6 diet.  
To evaluate our hypothesis, we performed immunohistochemistry, digital pathology, RT-
PCR, and liquid chromatography with tandem mass spectrometry. Our data 
demonstrated that the brain metastasis was found in mice fed with rich- ω-6 diet in mice 
treated with TCDD as compared with untreated mice.  Further, TCDD significantly 
induced CYP 1A1 and CYP 1B1 in mice brain tissue under ω-6 enriched diet. In 
addition, the levels of oxylipins in plasma demonstrated that epoxides 5,6 EET are 
increases after TCCD treatment, as well as various diols like 5,6-DiHETrE, 11,12-
DiHETrE, and 14,15-DiHETrE. 
iv 
 
These results provide us a future research direction on combining effects of diets and 
environment carcinogens to analyze the mechanism to be involved in the metastasis to 
brain from the lung tumor cells.  
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1. Introduction 
 
1.1 Hypothesis 
 
The hypothesis is that the lung tumor increases the metastasis to brain through, an 
AHR agonist like TCDD, which induce the expression of some cytochrome P450 in the 
brain of the mice that were fed with rich-⍵6 diet.  
 
1.2 Background 
 
1.2.1 Lung cancer statistics  
 
Lung carcinoma is one of the most common diagnosis cancers in the U.S1. Despite the 
overall trending of declining due to the advancement of modern medicine, lung cancer 
remains one of the lowest survival rates alone with liver cancer and pancreatic cancer1.  
In addition, It has been found that lung cancer in human patients frequently 
metastasizes to the brain2. The prognosis and the median survival of patients with lung 
cancer metastasis to the brain are both poor due to the rapid disease progression and 
limited treatment. 
 
1.2.2 Aryl Hydrocarbon Receptor (AHR) mediated induction of Cytochrome 
P450 in cancer 
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Aryl Hydrocarbon Receptor (AHR) is a nuclear receptor and numerous literature 
demonstrated that AHR is expressed in a broad pattern in different tissues of 
vertebrates, including different compartments of the brain3,4. 
2, 3, 7, 8-tetrachlorodibenzo-p-dioxin (TCDD) is a common AHR ligand as well as an 
environmental pollutant (Figure 1). 
 
 
 
 
 
 
 
Figure 1. TCDD chemical structure5 
 
Although the exact mechanism of action of TCDD to cause cancer is still unclear, the 
Aryl Hydrocarbon Receptor (AHR) has been proved to be the receptor of TCDD6. After 
binding to TCDD, the AHR translocated into the nucleus to bind to a specific DNA 
sequence as a transcription factor, activating transcription for some essential genes, 
including CYP1A1 and CYP1B1 in many tissues in all mammals (Figure 2)7-10. Because 
research has proved that TCDD can distribute in many different organs like lung, liver, 
and brain, the AHR in brain could potentially be activated 8,11,12. The induction of CYP 
1A1 and CYP 1B1 enzymes in lung and liver has been linked to tumor growth, 
angiogenesis, and metastasis8,13.  
In addition, previous research has shown that TCDD and some other AHR agonists like 
indole and polychlorinated biphenyls (PCBs) can both increase or inhibit tumor growth 
in mice models14,15.  
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Figure 2. TCDD and AHR binding9 
 
1.2.3 Omega 3/omega-6 PUFAs on cancer 
 
Dietary effects on health have been heavily studied. Among past studies, typical 
western diet compositions, which is described as high intake of omega-6 (ω-6) 
polyunsaturated fatty acids (PUFA) with the ω-6/ω-3 ratio of 20:1 like arachidonic Acid 
(ARA, C20:4, ω6) and linoleic (L.A., C18:2, ω6) acid, have drawn the linkage to adverse 
health effects like cancers16. In contrast with ω-6 PUFAs, omega-3 (ω-3) PUFAs, like 
eicosapentaenoic Acid (EPA, C20:5, ω3), and docosahexaenoic acid (DHA, C22:6, ω-
3), have been associated with beneficial health effects17. The metabolism of PUFA can 
be classified into three major pathways: the cyclooxygenase pathway, cytochrome P450 
pathway, and lipoxygenase pathway (Figure 3)18. Within the cytochrome P450 pathway, 
CYP 1A1 and CYP1B1 are essential enzymes that metabolize PUFA into epoxides, 
which are further metabolized into diols via epoxide hydrolase enzyme (EPHX2)19. It 
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has been demonstrated that EPHX2 expression varies between males and females due 
to the estrogen-dependent epigenetic regulation20. This difference of EPHX2 expression 
would potentially lead to different health outcomes between sex when feeding with the 
same dietary PUFA13. Experiments have shown that increasing the level of ⍵-6 PUFAs 
epoxides promotes cancer progression. On the other hand, the high level of ⍵-3 PUFAs 
epoxides presented an inhibitory effect on cancer progression17. The use of the epoxide 
hydrolase inhibitor will be important in our experiment because the conversion of 
epoxide to diols via EPHX2 is a rapid process21. Reducing the activity of EPHX2 would 
be necessary to investigate PUFA epoxides. Different oxygenated metabolites of 
PUFAs, known as oxylipins, play essential roles in our bodies. However, some of the 
oxylipins are positively related to the progression of cancer and metastasis22-27. A bulk 
of published literature focuses on how oxylipins (prostaglandins and lipoxins) affect 
primary brain cancer like glioblastoma as well as metastatic melanoma; however, the 
pathways that are involved are primarily Cyclooxygenase and Lipoxygenase 
pathways24,25,28-31. The cytochrome P450 pathway is not extensively studied in primary 
brain cancers, but some literature has found that under the cytochrome P450 pathway, 
one of the Arachidonic Acid (ARA) metabolites, called 20-HETE (20-
Hydroxyeicosatetraenoic Acid), participate in breast cancer metastasis23. 
Epoxyeicosatrienoic acids (EETs), which are ARA metabolites from CYP pathway, have 
been discovered to be mitogenic and angiogenic in the brain32. Previous studies have 
shown that TCDD-treated mice were experiencing changes of oxylipins in both lung and 
liver8. More specifically, elevated levels of certain EETs in xenograft cancer cells 
promote tumor growth and metastasis33,34. Thus, in order to investigate the influence of 
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TCDD-induced oxylipins in metastatic cancer to brain, either brain tissue oxylipins or 
plasma oxylipins quantification is needed. However, the research about how EETs 
involved in lung cancer metastasis to brain is still limited. 
 
 
Figure 3. PUFAs metabolic pathways18. Three enzymatic pathways metabolize arachidonic Acid into 
different metabolites including P.G.s (Prostaglandins) by COX, HETEs (Hydroxyeicosatetraenoic acids) 
by LOX and epoxides by CYP-450.   
 
1.2.4 Combined dietary and environmental effect on cancer progression 
 
We are exposing to different types of environmental carcinogens daily, so it is crucial to 
consider the combined effects of diets and environmental factors on cancer progression 
(Figure 4). As previously mentioned, TCDD as a common environmental pollutant, and 
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AHR ligand can activate AHR constantly, which in turn activates the PUFA metabolism 
pathway of CYP450. This research justification would be valuable to have a deeper 
understanding of PUFA dietary effects on cancer and even dietary treatment of cancer.   
 
Figure 4. Overall research justification. Diets components and environmental components are combining to 
influence cancer progression. This paper focuses on PUFAs and TCDD in brain metastasis from lung 
cancer cells.  
 
1.2.5 AHR agonists may reduce or enhance cancer progression based on 
dietary context 
 
In the most recent published paper, our group has demonstrated that environmental 
AHR agonists, such as TCDD, may decrease or promote lung cancer progression 
depending on the different composition of PUFA intake13. Specifically, TCDD declined 
the tumor growth and metastasis to lung and liver in -3 fed mice, whereas the opposite 
results can be observed in -6 fed mice13. Based on this finding, it is also interesting to 
see if the same effects of TCDD on lung cancer metastasis to brain can also be 
repeated depending on the different ratios of ω-6 to ω-3 PUFA intake.  
 
 
7 
 
2. Materials and method 
2.1 Chemicals 
 
TCDD (>99.99% purity) was purchased from Dow Chemical's Co. (Midland, MI, USA), 
and dissolved in 1,4-Dioxane (New Haven, Connecticut), and stored in the dark at 
−20°C. 1-Trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) urea (TPPU) was made 
based on the previously published work35.  
 
2.2 Cell lines and cell culture assays 
 
Lewis lung carcinoma cell line (LLC) (ATCC #CRL-1642™) was purchased from 
American Type Culture Collection (Manassas, VA). Cells were cultured in alpha Minimal 
Essential Medium (ɑ-MEM) (Gibco, Carlsbad, CA). LLC cell lines were given 10% fetal 
bovine serum (FBS, Omega Scientific, Tarzana, CA) and penicillin-streptomycin (P/S, 
Gibco) plus Fungizone. In vivo injection step, LLC cells were harvested from sub-
confluent cultures by using 0.05% trypsin-EDTA and then neutralized with cell culture 
medium at 4°C. Prior to re-suspension in serum-free alpha medium, the cells were 
washed three times in serum-free medium.  
 
2.3 Mouse husbandry and feeding 
 
C57BL/6 male mice at 5-weeks-old of age were purchased from the Jackson Laboratory 
(Bar Harbor, Maine). The mice were set up five per cage under the maintenance of 
UCLA DLAM of 3v vivarium, according to the ethical guidelines for animal handling 
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required by the UCLA Institutional Animal Care and Use Committee (IACUC). Each 
cage is ventilated with constant room temperature between 20℃-22℃. The mice room 
was provided with a 12-hour light and 12 hours dark cycle. The mice were fed with NIH-
31 open Formula Mouse/Rat diet 7013 from Envigo, Madison, Wisconsin (referred to as 
normal chow in this paper). After 72 hours of mice arrival, they were fed with either ⍵-3 
enriched diets (referred to as diet 29) or ⍵-6 enriched diets (indicated as diets 21). The 
ω-3 rich diet (diet 29) had a ω-6/ω-3 ratio of 1.1:1 (theoretical) and 1.5:1 (experimental) 
with 1% of PUFA content. The ω-6 enriched diet (diet 21) had the ω-6/ω-3 ratio of 20:1, 
which is highly similar to the real-life western diet ratio of ω-6/ω-3. Mice consumed 
equal amounts of calories per day on each diet, and the food was changed twice per 
week. These special diets were modifications of the AIN-93G mouse diet. Special diets 
were formulated to contain 3.8 Kcal/g with 19% of calories from protein (casein), 64% 
from carbohydrates, and 17% from fat (Envigo Teklad, Madison WI). 
Since polyunsaturated fatty acids are easily oxidized if exposed to air, the diets were 
stored in vacuum-sealed pouches at −80°C unless used. Water was provided ad 
libitum.  
 
2.4 Mouse tumor models 
 
The mice were randomly separated into two groups. They were fed with experimental 
diets and ad libitum for three weeks before the injection of cells. TPPU was added to the 
water and changed twice a week. TCDD was injected intraperitoneally with a 
concentration of 40 g/kg for the initial injection and 10 g/kg for the sequential 
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injections once a week. 1,4-Dioxane was selected as a solvent of TCDD instead of corn 
oil because corn oil content may affect the results of this diet study. The LLC cells were 
injected into the mice subcutaneously with 2×105 cell count. Two weeks after the 
injection of LLC cells, tumor growth was measured by an electronic Vernier caliper 
every other day until the termination of the experiment or until resection of the tumor. 
The dead mice were excluded from the data collection (4 out of 48 total). Tumor 
volumes were calculated from the formula: volume = (the shortest diameter)2 ×(the 
largest diameter)/2 ×(4.19)36. After the tumor reached a certain size calculated by the 
formula above, resection surgery was performed, and the wounds were closed by 
surgical stamps. Half of the tumors were stored in liquid nitrogen, and another half were 
put in formalin for histology use. Tumors were weighed right after resection. For the 
post-op care, Gabapentin (100 mg/kg orally) plus carprofen (5 mg/kg subcutaneously) 
was used as analgesics immediately after surgery, daily thereafter for three days, and 
then as needed. Three to five weeks after the surgery, mice were sacrificed based on 
their health status. The plasma was first collected and put in tubes with anticoagulants. 
The lung and brain were extracted from the mice. The model is shown in Figure 5. For 
lungs, half was frozen in liquid nitrogen and stored at -80℃, and the other half was fixed 
in formalin saline for immunohistochemistry. The intact brain was cut by a sagittal plane. 
Half of the brain was frozen in liquid nitrogen and stored at -80℃. Another half was fixed 
in formalin saline (Fisherbrand, Pittsburg, PA), Torrance, CA). The experiments were 
approved by the UCLA Institutional Animal Care, and Use Committee (IACUC), and the 
daily care and maintenance were followed based on guidelines.  
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2.5 Real-Time Reverse transcription PCR 
 
From each frozen tissue, the RNA was extracted by using the Trizol and chloroform. 
Then 1g of RNA was used for cDNA synthesis in a volume of 20 L. The presence of 
messenger RNA (mRNA) of CYP 1A1, CYP1B1, and EPHX2 was determined from total 
cDNA extracts obtained by miRneasy kit (QIAGEN). For RT-PCR, the Universal 
Taqman Master Mix II kit (Applied biosystems) was used. Taqman probes (CYP 1A1, 
CYP1B1, and Tubulin) and Taqman Universal Master Mix were used (Applied 
Biosystems). In addition, as control of expression, the Tubulin transcription was 
evaluated. The relative value of expression of the genes was calculated using the 
method 2-(∆∆Ct) comparing the expression of mRNA of CYP 1A1, CYP1B1, and 
EPHX2 related to Tubulin as an endogenous control. The RT-PCR was run in an 
Applied Biosystems 7500 real-time PCR machine.   
 
2.6 Hematoxylin and eosin stain  
 
Tissues were used for Mayer's hematoxylin and eosin (H&E) for histopathological 
examination of metastasis. Briefly. Sections of 4 µm of tissue were dewaxed in xylol and 
rehydrated through a series of solvents (xylene, 100% ethanol, 90% ethanol, 70% 
ethanol, and distilled water). Subsequently, tissues were merged in hematoxylin for one 
minute, followed by three washes in ethanol-HCl, one wash in water, and one wash in 
70% ethanol. After two minutes of treatment in eosin, the tissue was dehydrated under 
the following procedures: distilled water, 70% ethanol, 90% ethanol, 100% ethanol and 
xylene in baths with 5 minutes each. Lastly, the tissues were covered with resin and put 
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to dry at room temperature.  
 
2.7 Immunohistochemical (IHC) Analysis 
 
Slides from brain tumor tissue were used for Immunochemistry staining to detect CYP 
enzymes and EPHX2 protein.  
For immunochemical analysis, paraffin-fixed tissues were cut into four µm-thick sections 
blocks and stained by using the Vectastain Elite ABC HRP Kit (Vector; Burlingame, CA). 
Firstly, Sections were deparaffinized at 68 ℃ in xylene and dehydrated through three 
alcohol changes (100%, 90%, and 70% ethanol). Endogenous peroxidase blocking was 
in 3% hydrogen peroxide (hydrogen peroxide in methanol). Antigen retrieval was 
performed in 0.01M sodium citrate at 93 ℃. Slides were incubated with primary 
antibodies overnight at room temperature against CYP1A1 (1:1000 dilution) and CYP 
1B1 (1:1000 dilution) from Invitrogen (Carlsbad, CA), EPHX2 (1:1000 dilution) from 
Novus Biologicals (Littleton, CO).  
Then, sections were incubated with the Vectastain Elite ABC HRP Kit Secondary 
Antibody and DAB detection system (Vector Laboratories, Burlingame, CA).  The slides 
were counterstained with hematoxylin. Finally, the slides were dehydrated by increasing 
the concentration of ethanol and mounted with resin.  
The pictures of stained slides were taken by using an Aperio ScanScope CS (Leica, 
Nussloch, Germany), which produces 40x digital images.  
2.8 Tissue and LC/MS/MS analysis 
 
Oxylipins extraction and the measurement via liquid chromatography with tandem mass 
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spectrometry were performed as described previously37,38. Dr. Hammock group at UC 
Davis did the whole LC/MS/MS analysis. In short, plasma was put into liquid nitrogen. 10 
L of antioxidant cocktail solution (0.2 mg/mL of butylated hydroxytoluene (BHT) and 
EDTA) and 10 L of 100 nM isotope internal standard solution (including d4 6-ketoPGF1α, 
d4 PGE2, d4 TXB2, d4 LTB4, d11 14,15-DiHETrE, d4 9- HODE, d8 5HETE and d11 
11(12) EpETrE) were added. The plasma was stored under −80°C overnight. The 
LC/MS/MS analyses were carried out on an Agilent 1200 SL UHPLC system (Santa Clara, 
CA) coupled with AB Sciex 4000 QTRAP system (Foster City, CA) under negative MRM 
mode.  
 
2.9 Statistical analysis 
 
The data was analyzed by a two-tailed student T-test to compare two independent 
groups through Excel 2016. The Graph Pad Prism Version 5.0 software (San Diego, 
CA) was used to construct the graphs. A Chi-square test was used via the Quantpsy 
website calculator. Levels of significance are indicated as follows: *p<0.05, **p<0.01, 
***p<0.001. 
 
3. Results 
3.1 TCDD induced tumor brain metastasis from lung 
 
Based on the LLC metastasis model, Figure 5 presented H&E staining followed under 
different timeline. The mice were fed with a rich-6 diets and were exposed to TCDD 
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thought out the whole timeline. Roughly, about four weeks, we implanted the lung tumor 
and closely monitoring the size change. Primary tumor resection started when a certain 
size of the tumor is reached. The H&E staining analysis was presented at 20X 
magnification with darker red color in the TCDD group compared with the vehicle. Two 
weeks after the resection, we started to sacrifice the mice for the extraction of lung 
tissue. Metastasis in lung tissue was shown in 4X magnification. The larger area of dark 
red color in the TCDD treated group indicates more metastasis of LLC in lung tissue.  
At the same time of extracting the lung, we also collected the brain tissue. Black arrows 
on 20X magnification of brain H&E staining indicated more metastasis in brain tissue in 
the TCDD group in comparison with dioxane treated.  
14 
 
Figure 5. Experimental model. Based on the LLC metastasis model, this figure presented H&E staining followed 
under different timelines. The mice were fed with a rich-6 diet and were exposed to TCDD thought out the whole 
timeline. Roughly about four weeks, we implanted the lung tumor and closely monitoring the size change. Primary 
tumor resection started when a certain size of the tumor is reached. The H&E staining analysis was presented at 
20X magnification with darker red color in the TCDD group compared with the vehicle. Two weeks after the 
resection, we started to sacrifice the mice for the extraction of lung tissue. Metastasis in lung tissue was shown in 
4X magnification. The larger area of dark red color in the TCDD treated group indicates more metastasis of LLC in 
the lung tissue of the TCDD group. At the same time of extracting the lung, we also collected the brain tissue. Black 
arrows on 20X magnification of brain H&E staining indicated more metastasis in brain tissue in the TCDD group in 
comparison with dioxane treated.  
 
 
 
In Figure 6, we presented H&E staining for TCDD and dioxane treated groups. Black 
arrows indicated lung cancer cells metastasis to brain tissues. The 60X magnification on 
the right side of Figure 6A showed the histology of the lung cancer cells in brain tissue. 
The histology of the LLC metastasis in the brain was confirmed by an expert pathology 
from Mexican Children Hospital, Federico Gomez at Mexico City, Dr. Lourdes Cabrera. 
Figure 6B and 6C are the quantifications of the lung cells metastasis in brain. Figure 
6B shows that among all the TCDD treated mice, 80% of them was found metastasis 
under H&E analysis. None of the dioxane treated mice has metastasis. In addition, 
Figure 6C is showing the details of how we calculate 80% in Figure 6B, as well as the 
Chi-square test result. P = 0.018.  
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Figure 6. Mice fed with rich-6 diet and treated with TCDD shown metastasis to brain. In the H&E staining for 
TCDD and dioxane treated groups fed with rich-6 diet. The mice with brain metastasis were identified for an 
expert pathology. A. representative microphotographic 20 and 60x of brain tissue from mice treated or untreated 
with TCDD, and black arrows indicated lung cancer cells to metastases to brain tissues.   B and C are the 
quantifications of the number of mice that presented lung cells metastasis in brain. B shows that among all the 
TCDD treated mice, 80% of them was found metastasis under H&E analysis. None of the dioxane treated mice has 
metastasis. C. Chi-square test result. *p = 0.018.  
  
16 
 
3.2 TCDD induced CYP 1A1 and CYP 1B1 in brain 
 
CYP 1A1, CYP 1B1, and EPHX2 quantification in brain after TCDD treatment were 
done by both immunohistochemistry and RT-PCR. Figure 7A show representative 
microphotography of the immunohistochemistry of CYP 1A1 in brain tissue. The TCDD 
group presented more positive staining than the control group (dioxane). The IHC 
pictures were taken under 40x magnification. Figure 7B presents the RT-PCR of CYP 
1A1 expression to Tubulin. TCDD treated brain tissue has a significant increase in the 
expression of CYP 1A1 in brain tissue compared with the dioxane group (p<0.05).  
Figure 8A representative microphotography of the immunohistochemistry of CYP 1B1 
in brain tissue. The TCDD group presented more positive staining than the control 
group (dioxane), 40x magnification. Figure 8B presents the RT-PCR of CYP 1B1 
expression. We used Tubulin as an endogen. TCDD treated brain tissue has a 15 times 
increase in the expression of CYP 1B1 in brain tissue compared with the dioxane group 
(p<0.05).  
 
Figure 7. TCDD induction of CYP 1A1 in mice fed with rich-6 diet. A.  Immunohistochemistry staining between 
TCDD and dioxane (40x) (A). B.  RT-PCR shows a significant increase in CYP1A1 expression to Tubulin in TCDD 
treated group, *p<0.05.  
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Figure 8. TCDD induction of CYP 1B1 in mice fed with rich-6 diet. A.  Immunohistochemistry staining between 
TCDD and dioxane (40x) (A). B.  RT-PCR shows a significant increase in CYP1A1 expression to Tubulin in TCDD 
treated group, *p<0.05.  
 
3.3 TCDD and EPHX2 in brain 
 
Both immunohistochemistry and RT-PCR results of EPHX2 expression in brain tissue 
after TCDD treatment are showing in Figures 9A and 9B. The immunostaining indicates 
some positive staining in TCDD treated mice, but the RT-PCR results did not show a 
significant difference of EPHX2 in mice brain tissue after TCDD treatment. (p>0.05) 
Based on the previous finding that EPHX2 expression in the lung is different between 
male and female mice. We did the IHC to compare the expression in brain tissue 
between male and female mice under normal conditions (dioxane) (Figure 10). From 
the immunostaining, we found that in male brain tissue, there are more positive staining 
than in female brain tissue, which resembles the pattern of EPHX2 expression in lung 
tissue. However, RT-PCR analysis will be done later to confirm the finding from the 
immunohistochemistry assay.   
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Figure 9. Expression of EPHX2 in mice treated with TCDD and fed with rich-6 diet. A.  Immunohistochemistry 
staining between TCDD and dioxane (40x) (A). B.  RT-PCR shows not significantly different between TCDD treated 
and untreated mice. ns = not significant.  
 
 
 
 
 
 
 
 
 
Figure 10.  EPHX2 expression in male and female mice brain. The expression of EPHX2 was evaluated by 
immunohistochemistry in brain tissue from female and male mice.  
 
 
3.4 Oxylipins level change in mice plasma 
 
Several oxylipins from mice plasma were measured and listed in Table 1. The table 
consists of the change of 12 different oxylipins from three enzymatic pathways. For the 
mice fed with ω-6 enriched diets, we did not see a significant reduction in PGE2, PGD2, 
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and PGF2a when treating with TCDD versus dioxane (without TCDD). The same trend 
can also be observed in TXB 2 and LTB 4. For 20-HETE, a level increase was observed 
in ω-6 fed group with TCDD treatment, but it is not significant. For EETs, their 
downstream diols increased in TCDD treated mice fed with ω-6 enriched diets. It is 
interesting to notice that the only EET with significant change is 5,6-EET, which is 
decreased after TCDD treatment. No significant changes were observed from other 
EETs.  
 
                                 Table 1. Levels of oxylipin change in plasma.  
Plasma Oxylipins 
(pmol/ml) 
-6 enriched diet 
-TCDD-TPPU +TCDD-TPPU 
PGE2 0.6  0.2 0.8  0.1 
PGD2 0.5  0.1 0.7  0.1 
PGF2a 2.1  0.7 2  0.2 
TXB2 28.3  9.5 38.2 5.5 
LTB4 0.6  0.4 3.6  2.3 
20-HETE 0.3  0.1 0.5  0.1  
5,6-EET 1431.3  418 734.2  130.4 * 
11,12-EET 271.7  75.4 159.5  29.4 
14,15-EET 183.5  52 104.9  20.9 
5,6-DiHETrE 1.2  0.1 1.8  0.1 ** 
11,12-DiHETrE 0.8  0.1 2.2  0.3 ** 
14,15-DiHETrE 1.6  0.2 2.4  0.3 * 
Plasma oxylipin levels were quantified (pmol/ml) for mice in four different experimental groups. Listed oxylipins 
are prostaglandins E2, D2, F2α (PGE2, PGD2, and PGF2a), Thromboxane B2 (TXB2), Leukotriene B4 (LTB4), 20-
Hydroxyeicosatetraenoic Acid (20-HETE), epoxyeicosatrienoic acids (EETs), and dihydroxyicosatrienoic acids 
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(DiHETrEs, the diols of EETs). The number after  represents the standard error. Highlighted red color means 
oxylipins level with significant change, *p<0.05, **p<0.01 
 
 
 
4. Discussions 
 
4.1 Key findings 
 
Using the tumor transplantation/metastasis model, we demonstrated that TCDD 
enhances the primary lung cancer metastasis to brain when fed with rich-6 diet. This 
finding partially resembles our finding in a recently published paper that TCDD 
promoted the primary tumor growth and metastasis to the lung when mice are fed with 
rich-6 diet13. The previously published studies from our group already broke a field in 
which TCDD may affect tumor growth and metastasis differently depending on the 
dietary contexts. This new ground can be further explored not only in lung metastasis 
but also in brain metastasis. The next step for this study is to compare the lung cancer 
metastasis to brain between ω-6 fed mice and ω-3 fed mice to further test if TCDD 
retards the metastasis when the mice are fed with -3 diet, but enhances metastasis 
when the mice are fed with -6 diet.  
The results from immunohistochemistry and RT-PCR support the hypothesis that TCDD 
induces CYP 1A1 and CYP 1B1 expression in brain tissue when the mice are fed with 
ω-6 enriched diet. This finding is an important start to explore the influence of oxylipins 
on lung cancer metastasis to brain for several reasons: 1) CYP 450 are one of the three 
most important pathways to metabolize PUFA into downstream metabolites (Oxylipins). 
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2) Higher expression of CYP enzymes in brain can directly influence the level of 
oxylipins change in brain because TCDD and PUFAs have been proven to be able to 
pass the Blood-Brain Barriers (BBB)12,39. 3) TCDD, as an AHR agonist, can act on 
cancer progression to brain differently based on different ratio of ω-6 or ω-3 enriched 
diets intake13. Previous research has revealed that a 1:1 ratio of -6/-3 in the diet is 
the proper ratio of human evolution, and this ratio is recommended by nutritionists as a 
beneficial ratio as well40,41. However, due to agricultural advance and industrial 
evaluation, the balanced ratio of 1:1 ratio of -6/-3 in the diet has shifted to a high -6 
content diet with the ratio of 20:1. The use of diet 21 in our study is to resemble the 
western diet ratio. Future research on CYP enzymes and diets will offer a new 
perspective on cancer prevention.  
The plasma oxylipins of mice fed with ω-6 enriched diets demonstrate some interesting 
trends. EETs have previously been shown to be mitogenic and angiogenic in brain23. In 
ω-6 fed mice, the lower level of EETs in the TCDD treated group contradicted with our 
hypothesis that TCDD enhances the level of EETs under -6 enriched diet.14,15. This 
might be because, without TPPU, plasma oxylipins are rapidly metabolized by epoxide 
hydrolase to diols. In the table, all the DiHETrEs significantly increased after TCDD 
treatment, but the potential mechanism for this change is not clear. The other interesting 
trend is that 20-HETE, which has an important role in breast cancer metastasis23, 
increases with TCDD treatment in ω-6 fed mice, but the increase is not significant. Even 
though 20-HETE has not been heavily studied in brain metastatic cancers, this oxylipin 
can be studied more in the future.  
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For other oxylipins listed in table 1, they are primarily the products of the COX pathway 
and LOX pathway, which is not the focus in this paper. However, it will be valuable to 
show here for future investigations.  
 
4.2 Limitations and future work  
 
The method of harvesting the brain needs to be revised because the sagittal cut of brain 
collection will lead to some loss of metastatic evidence (RT-PCR half is unable to be 
evaluated for metastasis). In the future, we will not cut the whole brain into two pieces. 
Keeping the whole brain will help us see the location of metastatic lung carcinoma in 
brain. Besides, a morphology evaluation of LLC in brain H&E staining is not sufficient. 
We will identify some unique markers of LLC to differentiate from neuro cells. By doing 
so, we can confirm that the abnormal areas in brain H&E staining are LLC. Further, Due 
to limited time, H&E staining was only done in -6 fed mice. The ω-3 fed mice will be 
analyzed for metastasis in the future to observe the anti-cancer effect of ω-3 PUFAs 
and its metabolites.  
Another further work is the immunohistochemistry analysis of CYP 1A1 and 1B1 
expression, using the Aperio software to detect positive pixels of positive staining in a 
quantitative manner. This analysis is more accurate and objective than only presenting 
the pictures. In addition, female mice will be evaluated as well in comparison to male 
mice to see if sex plays a role in TCDD induction of CYP enzymes in brain under the 
same type of diet.  
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The plasma oxylipins data shows some huge variations, and some of the numbers 
present a high standard error as well. The repeat of the plasma oxylipins measurement 
is necessary to rule out the possibility that those trends are by chance. In addition, it 
would be more convincing and supportive for us to measure the oxylipins in brain 
directly because Oxylipins in plasma are decaying rapidly42. Brain oxylipins data will 
help us have a better visualization of the changes in brain, and this evidence will be 
more straightforward to link the changes to cancer progression.  
 
5. Conclusions and implications 
 
In conclusion, our data demonstrated that lung tumor brain metastasis was found in 
mice fed with rich- ω-6 diet in mice treated with TCDD as compared with untreated 
mice. Further, TCDD significantly induced CYP 1A1 and CYP 1B1 in mice brain tissue 
under ω-6 enriched diet. In addition, the levels of oxylipins demonstrated that epoxides 
5,6 EET are increases after TCCD treatment, as well of different diols. The data 
presented in this study provided us a future research direction on combining effects of 
diets and environment carcinogens to analyze the mechanism to be involved in the 
metastasis to brain from the lung tumor cells.  
Our study demonstrated a new mechanism in which the AHR activation and induction of 
CYP1 enzymes can enhance cancer metastasis from the lung to brain under typical 
western diet composition. Previous research has presented that CYP1 enzymes are 
capable of metabolizing environmental pollutants to cause cancer43. In our study, we 
demonstrated in the recently published literature that CYP1 enzymes are metabolizing 
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PUFA, which can affect cancer13. Thus, CYP1 enzymes can be viewed as an 
intermediate player between AHR and cancer activity.  
There are several implications of our main findings for future research. (1) The 
increasing CYP enzymes would metabolize the dietary PUFAs to oxylipins in the brain. 
(2) Alteration of certain types of oxylipins in the brain would be the potential mechanism 
to facilitate the metastasis of lung cancer brain metastasis. (3) Depending on the 
different ratio of ω-3 to ω-6 PUFAs in diets, TCDD, as a carcinogen, may have a 
protective role for cancer.  
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